Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C4049491
Disease: Verrucous keratosis
Verrucous keratosis
0.010 GeneticVariation disease BEFREE Patients treated with BRAF inhibitors (e.g. vemurafenib), a novel targeted therapy for advanced melanoma harbouring certain BRAF mutations, develop numerous adverse cutaneous side effects, including skin tumors such as squamous cell carcinoma or non-malignant verruciform keratinocyte proliferations, termed 'BRAF-inhibitor-associated verrucous keratosis (BAVK) lesions'. 24112647 2013